Correlation of preoperative serum prostate-specific antigen, clinical stage, and biopsy Gleason score with seminal vesicle involvement in prostate adenocarcinoma

被引：0
|
作者：
Ormsby, AH [1 ]
Skacel, M [1 ]
Brainard, JA [1 ]
Zippe, CD [1 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 1999年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
49
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [21] Prostate-specific antigen velocity and the detection of Gleason score 7 to 10 prostate cancer
    Punglia, Rinaa S.
    Cullen, Jennifer
    McLeod, David G.
    Chen, Yongmei
    D'Amico, Anthony V.
    CANCER, 2007, 110 (09) : 1973 - 1978
  • [22] Staging for prostate cancer - Time to incorporate pretreatment prostate-specific antigen and Gleason score?
    Roach, Mack, III
    Weinberg, Vivian
    Sandier, Howard
    Thompson, Ian
    CANCER, 2007, 109 (02) : 213 - 220
  • [23] THE ROLE OF TRANSRECTAL ULTRASOUND-GUIDED BIOPSY-BASED STAGING, PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN, AND BIOPSY GLEASON SCORE IN PREDICTION OF FINAL PATHOLOGICAL DIAGNOSIS IN PROSTATE-CANCER
    NARAYAN, P
    GAJENDRAN, V
    TAYLOR, SP
    TEWARI, A
    PRESTI, JC
    LEIDICH, R
    LO, R
    PALMER, K
    SHINOHARA, K
    SPAULDING, JT
    UROLOGY, 1995, 46 (02) : 205 - 212
  • [24] NOMOGRAM FOR PREDICTING THE RISK OF NODE INVOLVEMENT IN PROSTATE-CANCER GIVEN PRETREATMENT PROSTATE-SPECIFIC ANTIGEN AND GLEASON SCORE
    LEHRER, S
    SONG, HK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 509 - 510
  • [25] The effect of seminal vesicle-sparing radical prostatectomy on serum prostate-specific antigen level
    John, H
    Hauri, D
    Maake, C
    BJU INTERNATIONAL, 2003, 92 (09) : 920 - 923
  • [26] Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy
    Oh, Jong Jin
    Hong, Sung Kyu
    Lee, Jung Keun
    Lee, Byung Ki
    Lee, Sangchul
    Kwon, Oh Sung
    Byun, Seok-Soo
    Lee, Sang Eun
    BJU INTERNATIONAL, 2012, 110 (11B) : E494 - E499
  • [27] Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy Gleason score, and clinical T-stage
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Renshaw, AA
    Tomaszewski, JE
    Richie, JP
    Wein, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (05): : 1227 - 1233
  • [28] PROSTATE-SPECIFIC ANTIGEN AS A MARKER OF ADENOCARCINOMA OF PROSTATE
    KELLOKUMPULEHTINEN, P
    NURMI, M
    KOSKINEN, P
    IRJALA, K
    UROLOGICAL RESEARCH, 1989, 17 (04): : 245 - 249
  • [29] The association of the phosphatidylinositol-3-kinase pathway to Gleason Score, prostate-specific antigen and pathologic stage in prostate cancer
    Gottschalk, AR
    Weinberg, V
    Carroll, P
    Simko, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S474 - S474
  • [30] Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer
    William D. Figg
    Michael E. Franks
    David Venzon
    Paul Duray
    Michael C. Cox
    W. Marston Linehan
    W. Van Bingham
    James A. Eastham
    Eddie Reed
    Oliver Sartor
    World Journal of Urology, 2004, 22 : 425 - 430
12345